Skip to main content
OpenTrials
Completed

NCT Number: NCT00680966

Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD

The purpose of this study is to determine whether it is more effective to treat adolescents, with diagnoses of both depression and substance use disorder, with a treatment addressing the substance use first and then treating the depression or to first treat the depression and then treat the substance use or whether treating both disorders simultaneously is most effective.

It is expected that treatment of both disorders at the same time will be the most effective.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Oregon Research Institute

Eugene, Oregon, 97403, United States

About this study

Comorbidity is a well established aspect of adolescent psychopathology. The majority of adolescents entering treatment have more than one condition. This study will evaluate service delivery methods of integrating empirically supported interventions for depression and non-nicotine substance use disorders (SUD)in an effort to improve treatment engagement, response, and maintenance of gains. The two examined interventions are the Adolescent Coping With Depression course (ACWD) and Functional Family Therapy (FFT).

This study will expand upon previous research by systematically treating both depression and SUD. Over a 5 year period, 180 adolescents with depression/SUD and their parents/guardians will be recruited in Oregon and New Mexico and randomly assigned to 1 of 3 conditions: (a) FFT followed by ACWD, (b) ACWD followed by FFT, or (c) an intervention combining and augmenting FFT and ACWD (Integrated Treatment). Each treatment arm will consist of 24 sessions provided over 20 weeks. Participants will be assessed at intake, after the provision of 6, 12 (Mid-treatment), 18 and 24 (Post-treatment)treatment sessions, and at 6 and 12 month follow-ups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • DSM-IV-TR diagnosis of depression, defined as MDD, dysthymia, or substance-induced mood disorder meeting MDD or dysthymia symptom criteria
  • DSM-IV-TR diagnosis of one or more non-nicotine SUD
  • Some reported illicit drug use in the last 90 days
  • 13-17 years of age
  • parent or guardian willing to participate in study
  • basic English competency (ability to converse in English)

Exclusion criteria

  • Current and acute suicidal ideation at the level warranting inpatient treatment
  • current psychotic symptoms
  • the adolescent's sibling is already participating in the study
  • if on psychiatric medications, a significant change in dosage levels in the prior 4 weeks -

Treatment and study plan

Adolescent Coping With Depression/Functional Family Therapy

Behavioral

ACWD- Cognitive behavioral group therapy for depressed adolescents FFT - Family therapy to address substance use disorders in adolescents

Other names: FFT, ACWD

Primary outcomes

  1. Children's Depression Rating Scale

    Time frame: Intake, Mid-Treatment, Post, 6 months and 12 months follow-up

Secondary outcomes

  1. Time Life Follow Back

    Time frame: Intake, Mid-Treatment, Post, 6 months and 12 months follow-up

Sponsors and collaborators

Lead sponsor

Oregon Research Institute

Other

Registry information

Acronym: Sequencing

Important dates

Study start
2008
Primary completion
2012
Study completion
2013
First posted
May 20, 2008
Registry last updated
Mar 12, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.